Effectiveness and safety of orelabrutinib with rituximab and lenalidomide in low KPS score and elderly patients with newly diagnosed primary central nervous system lymphoma—a single-center retrospective study
Neurological Sciences · 2024
DOI: 10.1007/s10072-024-07348-4 ↗Kurz gefasst
Leserbrief in der Zeitschrift Neurological Sciences, 2024. Verfasst von Xiao-Ling Guo und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, The Second Hospital of Hebei Medical University, No. 215, Heping West Road, Shijiazhuang, 050000, Hebei, China. Hauptthemen laut MEDLINE: Rituximab, Central Nervous System Neoplasms, Lenalidomide. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Hematology, The Second Hospital of Hebei Medical University, No. 215, Heping West Road, Shijiazhuang, 050000, Hebei, China.
- Department of Hematology, The Second Hospital of Hebei Medical University, No. 215, Heping West Road, Shijiazhuang, 050000, Hebei, China. 8503116578@163.com.
- Department of Hematology, The Second Hospital of Hebei Medical University, No. 215, Heping West Road, Shijiazhuang, 050000, Hebei, China. jinhai1966@sina.cn.
Zitieren
APA
Guo, X. L., Zhao, Z. Y., Guo, X. F., Zuo, Y. B., Li, J. A., Nie, Z. Y., & Ren, J. H. (2024). Effectiveness and safety of orelabrutinib with rituximab and lenalidomide in low KPS score and elderly patients with newly diagnosed primary central nervous system lymphoma—a single-center retrospective study. Neurological Sciences. https://doi.org/10.1007/s10072-024-07348-4
Vancouver
Guo XL, Zhao ZY, Guo XF, Zuo YB, Li JA, Nie ZY, et al. Effectiveness and safety of orelabrutinib with rituximab and lenalidomide in low KPS score and elderly patients with newly diagnosed primary central nervous system lymphoma—a single-center retrospective study. Neurological Sciences. 2024. doi:10.1007/s10072-024-07348-4
BibTeX
@article{Guo2024,
author = {Guo, Xiao-Ling and Zhao, Zi-Yu and Guo, Xue-Fei and Zuo, Ya-Bei and Li, Jin-Ao and Nie, Zi-Yuan and Ren, Jin-Hai},
title = {Effectiveness and safety of orelabrutinib with rituximab and lenalidomide in low KPS score and elderly patients with newly diagnosed primary central nervous system lymphoma—a single-center retrospective study},
journal = {Neurological Sciences},
year = {2024},
doi = {10.1007/s10072-024-07348-4}
}
EUVIMED